Literature DB >> 9636625

Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.

D S Bruce1, E S Woodle, K A Newell, J M Millis, D C Cronin, G E Loss, H P Grewal, C T Siegel, S Pellar, M A Josephson, J R Thistlethwaite.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9636625     DOI： 10.1016/s0041-1345(98)00348-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 2.  Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.

Authors:  C J Dunn; A J Wagstaff; C M Perry; G L Plosker; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Transplant therapy for type 1 diabetes mellitus.

Authors:  G E Loss; H P Grewal
Journal:  Ochsner J       Date:  2001-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.